Am J Transplant, Volume 21, Suppl 3 Archives - Page 120 of 139 - ATC Abstracts

2021 American Transplant Congress
COVID-19 in Hospitalized Kidney Transplant Recipients: Clinical Course, Prognostic Factors and Differences Between First and Second Waves
N. Macías, M. Rodríguez Ferrero, A. Acosta, J. Carbayo, Á. González Rojas, A. Muñoz de Morales, A. García Prieto, M. Goicoechea
Nephrology, Hospital Gregorio Marañón, Madrid, Spain
*Purpose: The aim was to describe the clinical course and management of SARS-CoV-2 infection in kidney transplant recipients (KTR) hospitalized with COVID-19, identify risk factors…
2021 American Transplant Congress
Covid-19 Caseload and Management Practices Vary by Program-Level Factors: A Multinational Survey Study
S. Sandal¹, B. Boyarsky², P. Chiang², A. Massie², D. Segev², M. Cantarovich¹
¹McGill University, Montreal, QC, Canada, ²Johns Hopkins University, Baltimore, MD
*Purpose: During the pandemic, the COVID-19 patient caseload (CPC) is thought to be highly variable and likely dependant on the cumulative COVID-19 incidence (CCI) of…
2021 American Transplant Congress
Evaluation of Low Dose Famciclovir as Herpes Simplex Virus and Varicella Zoster Virus Prophylaxis in Cytomegalovirus Low Risk Solid Organ Transplant Recipients
M. Cote, A. Cubley, C. Rogers, S. Shao, C. N. Kotton
Massachusetts General Hospital, Boston, MA
*Purpose: Famciclovir is recommended for herpes simplex virus (HSV) and varicella-zoster virus (VZV) prophylaxis in cytomegalovirus (CMV) low risk (both donor and recipient CMV seronegative)…
2021 American Transplant Congress
Covid Infection Among Kidney Transplant Recipients: Management and Outcomes
A. Price, K. Soliman, C. Zayas, V. Rao, M. Casey, D. Taber, M. Posadas Salas
Medical University of South Carolina, Charleston, SC
*Purpose: COVID pandemic has posed a significant challenge among kidney transplant recipients (KTR) due to their immunocompromised state. There is uncertainty on immunosuppression management among…
2021 American Transplant Congress
Conversion from Tacrolimus to Envarsus in Rapid Metabolizers for Prevention of BK Infection
G. Towns, G. Agarwal, C. Kew
Transplant Nephrology, UAB, Birmingham, AL
*Purpose: The incidence of BK virus infection is high among rapid metabolizers (RM) in kidney transplant (KT) patients. RM can be identified using validated and…
2021 American Transplant Congress
Organ Decline Rate and Outcomes of Shared Kidneys from OneLegacy OPO Donation Service Area in Los Angeles
M. Hussain¹, P. Homkalrias¹, K. Wheeler², G. Danovitch¹, S. Bunnapradist¹
¹UCLA David Geffen School of Medicine, Los Angeles, CA, ²OneLegacy, Los Angeles, CA
*Purpose: Background: 20% recovered kidneys are discarded in the US. Southern California has a high number of End-Stage Kidney Disease patients and the waitlist time…
2021 American Transplant Congress
Comparison of Kidney Transplantation Outcomes Between Donors After Controlled Circulatory Death and Brain Death Donors in Catalonia, Spain
J. Juega¹, M. Pérez-Sáez², J. Comas³, A. Zapatero⁴, M. Crespo², J. Tort³, R. Lauzurica¹, J. Pascual²
¹Nephrology, Germans Trias i Pujol Hospital, Badalona, Barcelona, Spain, ²Nephrology, Hospital del Mar, Barcelona, Spain, ³Departament de Salut, Organització Catalana de Trasplantaments (OCATT), Barcelona, Spain, ⁴Intensive care unit, Hospital del Mar, Barcelona, Spain
*Purpose: The number of kidney transplants (KT) from controlled cardiac death donors (cDCD) has exponentially increased in Spain during the last years. Results from cDCD…
2021 American Transplant Congress
A Kidney Waitlist Outcomes Timeline to Visualize Candidate Offers and Outcomes
C. Schaffhausen¹, J. Miller², A. Matas³, A. Israni⁴, A. Wey⁵, A. Hart⁴
¹Hennepin Healthcare Research Institute / University of Minnesota (UMN), Minneapolis, MN, ²Chronic Disease Research Group, Minneapolis, MN, ³Department of Surgery, UMN, Minneapolis, MN, ⁴Hennepin Healthcare / UMN, Minneapolis, MN, ⁵Scientific Registry of Transplant Recipients, Minneapolis, MN
*Purpose: While transplant centers closely monitor posttransplant outcomes for each transplant recipient, centers currently lack data to monitor waitlist outcomes of individual candidates. Candidates who…
2021 American Transplant Congress
Attitudes of Obese Kidney Transplant Candidates Towards Bariatric Surgery
C. LaVerne, V. Thompson, G. Aguiluz, P. DiCocco, J. Almario Alvarez, M. Spaggiari, I. Tang, I. Tzvetanov, E. Benedetti
Surgery, University of Illinois Hospital & Health Sciences System, Chicago, IL
*Purpose: Obesity is an epidemic in the US and increasingly prevalent in kidney transplant candidates. Surgical weight-loss interventions are effective and reduce transplant-related complications. They…
2021 American Transplant Congress
Dosing Weight of Rabbit Antithymocyte Globulin and Outcomes Among Kidney Transplant Patients Treated for Rejection
C. Patton, K. Cunningham, C. D'Agostino, A. Novak, M. Kapugi, K. Lang, C. Kane
Pharmacy, Northwestern Memorial Hospital, Chicago, IL
*Purpose: Rabbit antithymocyte globulin (rATG) is FDA approved for kidney transplant induction therapy and treatment of T-cell mediated rejection (TCMR). While prior studies comparing dosing…